Great find PoPo! Thank you for posting... :-) Saguaro's market focus is in two key areas: the life sciences (both medical device and pharmacology) and the internet-based application development industries. The firm's focus is on the private placements of growth equity and debt in amounts ranging between $5M to $50M. In certain circumstances, Saguaro also makes direct investments into privately held companies that fit the founder's investment criteria.
This could be a group that will be helping Regen BioPharma through the IPO process... perhaps even doing an additional private placement offering... which would be huge news! Let's hope that is the case that is happening here! Best wishes everyone! ;-)